ImageneBio, Inc. IMA 深 滬
已收盤 05-22 16:00:00 美东时间
5.56
+0.040
+0.72%
華盛通- 最 高5.70
- 今 開5.52
- 成交量 1.13万股
- 最 低 5.50
- 昨 收 5.52
- 總市值 6.27万
- 52周最高 18.00
- 市盈率 靜 --
- 換手率 0.10%
- 52周最低 3.94
- 委 比 90.48%
- 總股本 1.13万
- 歷史最高 451.32
- 量 比 0.73
- 振 幅 3.62%
- 歷史最低 3.94
- 每 手 1
- 風險率 4.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
Wedbush Reiterates Underperform on ImageneBio, Maintains $2 Price Target
Wedbush analyst Martin Fan reiterates ImageneBio (NASDAQ:IMA) with a Underperform and maintains $2 price target.
05-11 20:31
ImageneBio Q1 EPS $(0.95) Misses $(0.70) Estimate
ImageneBio (NASDAQ:IMA) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.70) by 35.71 percent.
05-08 04:44
美股夜盘 | Synergy CHC Corp.涨106.85%，Sana Biotechnology, Inc.涨23.36%
Synergy CHC Corp.涨106.85%；Sana Biotechnology, Inc.涨23.36%；GoPro, Inc. Class A涨18.73%
04-14 13:01
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 76.7% to $0.18 du...
04-13 20:05
Market-Moving News for April 13th
IMA: 41% | ImageneBio Raises $30M Via Private Institutional Placement To Fund Hair Loss And Skin Disease Treatments IDYA: 37% | IDEAYA Biosciences and Servier's Topline Data From Phase 2/3 OptimUM-02 Trial
04-13 19:21
ImageneBio Raises $30M Via Private Institutional Placement To Fund Hair Loss And Skin Disease Treatments
ImageneBio, Inc. (NASDAQ:IMA)("Imagene" or the "Company") today announced it has entered into a definitive securities purchase agreement with certain institutional investors in a private placement that is expected to
04-13 19:06
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Apellis Pharmaceuticals (NASDAQ:APLS) shares moved upwards by 138.8% t...
03-31 20:05
ImageneBio Q4 EPS $(6.73) Misses $(1.44) Estimate
ImageneBio (NASDAQ:IMA) reported quarterly losses of $(6.73) per share which missed the analyst consensus estimate of $(1.44) by 368.34 percent.
03-10 20:06
美股大行评级 | 安捷伦科技、Keysight、先科电子获多家大行上调目标价；摩根大通下调亿航智能评级至"中性"，目标价下调至13美元
今日重点评级关注：HC Wainwright & Co.：维持BiomX"买入"评级，目标价从15美元升至26美元；Clear Street：维持Diversified Energy"买入"评级，目标价从23美元升至25美元
2025-11-26 10:07
